Page 9 - Transcode Therapeutics News Today

BOSTON, May 20, 2022 -- TransCode Therapeutics, Inc. today announced that it will be presenting at the H.C. Wainwright Global Investment Conference. The in-person venue for the hybrid event is the... | May 20, 2022

Share: Industry Experts Provide Added Depth to Board of Directors and Advisory Board TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory Board. Philippe Calais, Pharm D, Ph.D., President, Chief Executive Officer and a director of MatriSys Bioscience, Inc., has been elected Chairman of the Board of Directors of TransCode. Dr. Calais has served on ...